Similar Papers

Paper Title
Journal
Date
Author
Clinical applicability of guideline-recommended molecular targets and genome-targeted cancer therapies.
Ariadna Tibau ... Jerry Avorn
Journal of Clinical Oncology | VOL. 42
Ariadna Tibau, et. al.Ariadna Tibau ... Jerry Avorn
01 Jun 2024
Abstract PO5-10-08: Clinical Value of Molecular Targets and Genome-Targeted Cancer Therapies Recommended by the National Comprehensive Cancer Network for Advanced Breast Cancer
Ariadna Tibau ... Thomas J Hwang
Cancer Research | VOL. 84
Ariadna Tibau, et. al.Ariadna Tibau ... Thomas J Hwang
02 May 2024
Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies
Ariadna Tibau ... Aaron S Kesselheim
JAMA Oncology | VOL. 10
Ariadna Tibau, et. al.Ariadna Tibau ... Aaron S Kesselheim
04 Apr 2024
Abstract PO4-10-12: Value of Molecular Targets and Genome-Targeted Therapies FDA-Approved for Metastatic Breast Cancer, 2006-2023
Ariadna Tibau ... Jerry Avorn
Cancer Research | VOL. 84
Ariadna Tibau, et. al.Ariadna Tibau ... Jerry Avorn
02 May 2024
View more papers

More From: BMJ

Paper Title
Journal
Date
Author
India’s organ transplant paradox: women donate the most and receive the least
Rupsa Chakraborty
BMJ | VOL. 388
Rupsa ChakrabortyRupsa Chakraborty
07 Feb 2025
Political changes and healthcare in Canada
Colleen M Flood ... Greg Marchildon
BMJ | VOL. 388
Colleen M Flood, et. al.Colleen M Flood ... Greg Marchildon
07 Feb 2025
Police consider manslaughter charges in 200 cases of harm and death at Brighton hospital
Clare Dyer
BMJ | VOL. 388
Clare DyerClare Dyer
07 Feb 2025
Malaria: African leaders pledge to tackle funding gap amid uncertainty over foreign aid
Gilbert Nakweya
BMJ | VOL. 388
Gilbert NakweyaGilbert Nakweya
07 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.